Has been treated with felbamate or vigabatrin within the past 6 months prior to Screening if a subject has been previously treated with vigabatrin a visual perimetry test prior to screening or within the past 6 months must show normal visual fields or no worsening of recognized visual field abnormalities as compared with prior to vigabatrin treatment 